Harrow HROW
NASDAQ HROW
$30.48 -0.13 (-0.42%)
At close: Oct 2, 2026 · 4:00 PM EDT

Harrow (HROW) Change in Account Payables (2010 - 2012)

Updated

Harrow's Change in Account Payables was $38,096 in Q1 2012, down 56.3% from $87,184 a year earlier and down 5.2% from the prior quarter.

Analysis

Harrow (HROW) Change in Account Payables (2010 - 2012) Analysis & Trends

On a trailing twelve-month basis, Harrow's Change in Account Payables was $95,892 through Mar 31, 2012; for FY2011, it came in at $144,980.

  • In earlier years, Change in Account Payables was -$607,382 in FY2010.
  • Quarterly Change in Account Payables has moved between -$46,347 (Q3 2010) and $87,184 (Q1 2011) over five years.
  • Per Business Quant data, HROW's Change in Account Payables in the three quarters before Q1 2012 was $40,201 (Q4 2011), $2,349 (Q3 2011) and $15,246 (Q2 2011).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -70.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 18.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Harrow 1.15 Bn 821.29 Mn 50.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2012 38,096.00
Dec 31, 2011 40,201.00
Sep 30, 2011 2,349.00
Jun 30, 2011 15,246.00
Mar 31, 2011 87,184.00
Dec 31, 2010 -28,526.00
Sep 30, 2010 -46,347.00
API Access

Harrow Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=HROW&period=max&api_key=YOUR_API_KEY